PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: GlobeNewswire
MENLO PARK, Calif. and WOBURN, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample preparation technologies, today announced a joint workflow has been developed for robust HiFi sequencing of formalin-fixed, paraffin-embedded (FFPE) tissue samples. The protocol will be formally presented at the upcoming American Association for Cancer Research (AACR) Annual Meeting. This solution integrates Covaris’ truXTRAC® FFPE extraction technology with PacBio’s Kinnex™ library preparation and sequencing on the Revio system, delivering a streamlined workflow from sample to sequencing. FFPE samples are among the most abundant and clinically relevant sources of biological material, particularly in oncology research. However, DNA damage and fragmentation caused by fixation have historically limited their compatibility with long-read sequencing. The combined
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- PacBio to Report First Quarter 2026 Financial Results on May 7, 2026GlobeNewswire
- Pacific Biosciences of California (PACB) had its price target lowered by Barclays PLC from $1.50 to $1.00. They now have an "underweight" rating on the stock.MarketBeat
- Pacific Biosciences (PACB) Garnering Attention Amid Involvement in Trillion Gene Atlas Program [Yahoo! Finance]Yahoo! Finance
- Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note [Yahoo! Finance]Yahoo! Finance
PACB
Earnings
- 2/12/26 - Beat
PACB
Sec Filings
- 4/10/26 - Form 4
- 4/3/26 - Form 4
- 4/1/26 - Form 144
- PACB's page on the SEC website